Valeant acquires branded OTC company PharmaSwiss for $488M, plus up to $41.8M in milestones

PharmaSwiss S.A.

Switzerland / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Valeant Pharmaceuticals International Inc.

Canada / Mid-Cap Biopharma ($1-$50 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed